| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Queensland Cancer Fund Research Laboratories [K. S., S. C., D. W., F. A., P. C., I. M., C. P., G. K., M. F. L.] and Leukaemia Foundation of Queensland Research Laboratories [C. L., S-l. L.], The Queensland Institute of Medical Research, Herston, Brisbane, Queensland 4029, Australia; Hybridoma Unit, George S. Wise Faculty of Life Sciences [L. B-S.], and Department of Human Genetics, Sackler School of Medicine [N. I. S., Y. S.], Tel Aviv University, Ramat Aviv 69978, Israel; Department of Pathology, University of Melbourne, Parkville, Victoria 3052, Australia [P. W.]; and Department of Surgery, University of Queensland, Herston, Brisbane, Queensland 4029, Australia [M. F. L.]
ATM, the gene mutated in the human immunodeficiency disorder ataxia-telangiectasia (A-T), plays a central role in recognizing ionizing radiation damage in DNA and in controlling several cell cycle checkpoints. We describe here a murine model in which a nine-nucleotide in-frame deletion has been introduced into the Atm gene by homologous recombination followed by removal of the selectable marker cassette by Cre-loxP site-specific, recombination-mediated excision. This mouse, Atm-
SRI, was designed as a model of one of the most common deletion mutations (7636del9) found in A-T patients. The murine Atm deletion results in the loss of three amino acid residues (SRI; 25562558) but produces near full-length detectable Atm protein that lacks protein kinase activity. Radiosensitivity was observed in Atm-
SRI mice, whereas the immunological profile of these mice showed greater heterogeneity of T-cell subsets than observed in Atm-/- mice. The life span of Atm-
SRI mice was significantly longer than that of Atm-/- mice when maintained under nonspecific pathogen-free conditions. This can be accounted for by a lower incidence of thymic lymphomas in Atm-
SRI mice up to 40 weeks, after which time the animals died of other causes. The thymic lymphomas in Atm-
SRI mice were characterized by extensive apoptosis, which appears to be attributable to an increased number of cells expressing Fas ligand. A variety of other tumors including B-cell lymphomas, sarcomas, and carcinomas not seen in Atm-/- mice were observed in older Atm-
SRI animals. Thus, expression of mutant protein in Atm-
SRI knock-in mice gives rise to a discernibly different phenotype to Atm-/- mice, which may account for the heterogeneity seen in A-T patients with different mutations.
This article has been cited by other articles:
![]() |
A. K. Ahuja, R. C. Barber, R. J. Hardwick, M. M. Weil, P. C. Genik, D. J. Brenner, and Y. E. Dubrova The effects of Atm haploinsufficiency on mutation rate in the mouse germ line and somatic tissue Mutagenesis, September 1, 2008; 23(5): 367 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Rimkus, R. J. Katzenberger, A. T. Trinh, G. E. Dodson, R. S. Tibbetts, and D. A. Wassarman Mutations in String/CDC25 inhibit cell cycle re-entry and neurodegeneration in a Drosophila model of Ataxia telangiectasia Genes & Dev., May 1, 2008; 22(9): 1205 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lu, K. Shen, Y. Wang, S. J. Santner, J. Chen, S.C. Brooks, and Y.A. Wang Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors Carcinogenesis, April 1, 2006; 27(4): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shahrabani-Gargir, T. K. Pandita, and H. Werner Ataxia-Telangiectasia Mutated Gene Controls Insulin-Like Growth Factor I Receptor Gene Expression in a Deoxyribonucleic Acid Damage Response Pathway via Mechanisms Involving Zinc-Finger Transcription Factors Sp1 and WT1 Endocrinology, December 1, 2004; 145(12): 5679 - 5687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ward and D. E. Devor-Henneman Mouse Models of Human Familial Cancer Syndromes Toxicol Pathol, January 1, 2004; 32(1_suppl): 90 - 98. [Abstract] [PDF] |
||||
![]() |
P. Chen, C. Peng, J. Luff, K. Spring, D. Watters, S. Bottle, S. Furuya, and M. F. Lavin Oxidative Stress Is Responsible for Deficient Survival and Dendritogenesis in Purkinje Neurons from Ataxia-Telangiectasia Mutated Mutant Mice J. Neurosci., December 10, 2003; 23(36): 11453 - 11460. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qi, M. A. Strong, B. O. Karim, M. Armanios, D. L. Huso, and C. W. Greider Short Telomeres and Ataxia-Telangiectasia Mutated Deficiency Cooperatively Increase Telomere Dysfunction and Suppress Tumorigenesis Cancer Res., December 1, 2003; 63(23): 8188 - 8196. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. R. Thorstenson, A. Roxas, R. Kroiss, M. A. Jenkins, K. M. Yu, T. Bachrich, D. Muhr, T. L. Wayne, G. Chu, R. W. Davis, et al. Contributions of ATM Mutations to Familial Breast and Ovarian Cancer Cancer Res., June 15, 2003; 63(12): 3325 - 3333. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |